ICON PLC

NASDAQ ICLR

Download Data

ICON PLC Market Capitalization on April 12, 2024: USD 25.24 B

ICON PLC Market Capitalization is USD 25.24 B on April 12, 2024, a 46.19% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • ICON PLC 52-week high Market Capitalization is USD 28.15 B on March 12, 2024, which is 11.53% above the current Market Capitalization.
  • ICON PLC 52-week low Market Capitalization is USD 15.04 B on May 04, 2023, which is -40.44% below the current Market Capitalization.
  • ICON PLC average Market Capitalization for the last 52 weeks is USD 21.20 B.
SV Wall Street

Don’t Miss A Beat

Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.

NASDAQ: ICLR

ICON PLC

CEO Dr. Steven A. Cutler MBA, Ph.D.
IPO Date May 15, 1998
Location Ireland
Headquarters South County Business Park, Dublin, Ireland, 18
Employees 41,100
Sector Healthcare
Industry Diagnostics & research
Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Similar companies

CRL

Charles River Laboratories

USD 241.34

-2.06%

LH

Laboratory Corporation of America Holdings

USD 205.73

-0.37%

NEOG

Neogen Corporation

USD 12.38

-4.77%

QGEN

Qiagen NV

USD 40.18

-2.40%

TWST

Twist Bioscience Corp

USD 30.68

-6.12%

WAT

Waters Corporation

USD 322.66

-4.51%

StockViz Staff

April 14, 2024

Any question? Send us an email